<SEC-DOCUMENT>0001517022-23-000004.txt : 20230525
<SEC-HEADER>0001517022-23-000004.hdr.sgml : 20230525
<ACCEPTANCE-DATETIME>20230525164409
ACCESSION NUMBER:		0001517022-23-000004
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230525
DATE AS OF CHANGE:		20230525

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akebia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001517022
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				208756903
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-36352
		FILM NUMBER:		23961523

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-2098

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Dahan Michel
		CENTRAL INDEX KEY:			0001669737

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O AKEBIA THERAPEUTICS, INC.
		STREET 2:		245 FIRST STREET, SUITE 1100
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001669737</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001517022</issuerCik>
      <issuerName>Akebia Therapeutics, Inc.</issuerName>
      <secFileNumber>001-36352</secFileNumber>
      <issuerAddress>
        <com:street1>245 FIRST STREET</com:street1>
        <com:city>CAMBRIDGE</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02142</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>617-871-2098</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Dahan Michel</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Morgan Stanley Smith Barney LLC</name>
        <address>
          <com:street1>1 New York Plaza, 38th Floor</com:street1>
          <com:city>New Yord</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10004</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>95478</noOfUnitsSold>
      <aggregateMarketValue>116760.00</aggregateMarketValue>
      <noOfUnitsOutstanding>185928121</noOfUnitsOutstanding>
      <approxSaleDate>05/25/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>05/25/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Akebia Therapeutics, Inc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>95478</amountOfSecuritiesAcquired>
      <paymentDate>05/25/2023</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Michel Dahan</name>
        <address>
          <com:street1>c/o 245 First Street</com:street1>
          <com:city>Cambridge</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02142</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Restricted Stock</securitiesClassTitle>
      <saleDate>03/01/2023</saleDate>
      <amountOfSecuritiesSold>20412</amountOfSecuritiesSold>
      <grossProceeds>17912.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Michel Dahan</name>
        <address>
          <com:street1>c/o 245 First Street</com:street1>
          <com:city>Cambridge</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02142</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Restricted Stock</securitiesClassTitle>
      <saleDate>02/27/2023</saleDate>
      <amountOfSecuritiesSold>10090</amountOfSecuritiesSold>
      <grossProceeds>8205.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>05/25/2023</noticeDate>
      <signature>Carolyn Rucci</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
